Literature DB >> 12353144

The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.

Suguru Yonezawa1, Akiko Nakamura, Michiko Horinouchi, Eiichi Sato.   

Abstract

BACKGROUND/
PURPOSE: Mucins are high molecular weight glycoproteins that have oligosaccharides attached to the apomucin protein backbone by O-glycosidic linkages. Here, we report the expression of MUC1 mucin (membrane-bound mucin), MUC2 mucin (intestinal-type secretory mucin), and MUC5AC mucin (gastric-type secretory mucin) in invasive ductal carcinomas (IDCs; n = 46) and intraductal papillary-mucinous neoplasms (IPMNs; n = 33) of the pancreas, and the relationship of this expression with malignant potential.
METHODS: To clarify the precise expression pattern of mucins in IPMNs, we classified IPMNs into three histologic subtypes; IPMN-dark cell type ( n = 19), IPMN-clear cell type ( n = 10), and IPMN-compact cell type ( n = 4).
RESULTS: IDC, with a poor outcome, showed a pattern of MUC1(+), MUC2(-), and MUC5AC(+ or -). In contrast, IPMN-dark cell type tumors, with a fairly favorable outcome, showed a pattern of MUC1(-), MUC2(+), and MUC5AC (+), and IPMN-clear cell type tumors, with a favorable outcome, showed a pattern of MUC1(-), MUC2(-), and MUC5AC(+). On the other hand, IPMN-compact cell type tumors showed a pattern of MUC1(+), MUC2 (-), and MUC5AC(+). In IPMN-dark cell type tumors with carcinomatous change showing invasive growth, the invasive areas acquired a characteristic of MUC1 expression that was usually seen in IDC, although their main noninvasive lesions showed no MUC1 expression. The IPMN-compact cell type tumors usually showed high cellular atypia and frequent MUC1 expression, even in the noninvasive areas.
CONCLUSIONS: Our study of the mucin expression pattern in IDC and IPMN shows that this pattern may be related to the biological behavior of pancreatic tumors and their malignant potential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353144     DOI: 10.1007/s005340200037

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  39 in total

1.  Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.

Authors:  Olca Basturk; Michael F Berger; Hiroshi Yamaguchi; Volkan Adsay; Gokce Askan; Umesh K Bhanot; Ahmet Zehir; Fatima Carneiro; Seung-Mo Hong; Giuseppe Zamboni; Esra Dikoglu; Vaidehi Jobanputra; Kazimierz O Wrzeszczynski; Serdar Balci; Peter Allen; Naoki Ikari; Shoko Takeuchi; Hiroyuki Akagawa; Atsushi Kanno; Tooru Shimosegawa; Takanori Morikawa; Fuyuhiko Motoi; Michiaki Unno; Ryota Higuchi; Masakazu Yamamoto; Kyoko Shimizu; Toru Furukawa; David S Klimstra
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Quantitative assessment of the diagnostic role of MUC1 in pancreatic ductal adenocarcinoma.

Authors:  Siliang Wang; Xiaodong Chen; Meiyue Tang
Journal:  Tumour Biol       Date:  2014-06-11

3.  Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.

Authors:  Olca Basturk; Volkan Adsay; Gokce Askan; Deepti Dhall; Giuseppe Zamboni; Michio Shimizu; Karina Cymes; Fatima Carneiro; Serdar Balci; Carlie Sigel; Michelle D Reid; Irene Esposito; Helena Baldaia; Peter Allen; Günter Klöppel; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2017-03       Impact factor: 6.394

4.  Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.

Authors:  Federica Castelli; Davide Bosetti; Riccardo Negrelli; Valerio Di Paola; Lisa Zantedeschi; Anna Ventriglia; Riccardo Manfredi; Roberto Pozzi Mucelli
Journal:  Radiol Med       Date:  2013-06-26       Impact factor: 3.469

5.  Precursor lesions of pancreatic cancer.

Authors:  Suguru Yonezawa; Michiyo Higashi; Norishige Yamada; Masamichi Goto
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

6.  MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.

Authors:  M Saitou; M Goto; M Horinouchi; S Tamada; K Nagata; T Hamada; M Osako; S Takao; S K Batra; T Aikou; K Imai; S Yonezawa
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

7.  A series of 64 cases of pancreatic cystic neoplasia from an institutional study of China.

Authors:  Yuan Ji; Wen-Hui Lou; Da-Yong Jin; Tian-Tao Kuang; Meng-Su Zeng; Yun-Shan Tan; Hai-Ying Zeng; Akesu Sujie; Xiong-Zeng Zhu
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

8.  Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.

Authors:  Heewon A Kwak; Xiuli Liu; Daniela S Allende; Rish K Pai; John Hart; Shu-Yuan Xiao
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

Review 9.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

10.  Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray.

Authors:  Mikiko Takikita; Sean Altekruse; Charles F Lynch; Mark T Goodman; Brenda Y Hernandez; Mark Green; Wendy Cozen; Myles Cockburn; Maria Sibug Saber; Marie Topor; Chris Zeruto; Behnoush Abedi-Ardekani; Marsha E Reichman; Stephen M Hewitt
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.